Otto Krieger
Impact in
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Genetics top 2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 21
- Acute Myeloid Leukemia Research 18
- Chronic Myeloid Leukemia Treatments 4
- Genetics 11
- Myeloproliferative Neoplasms: Diagnosis and Treatment 6
- Co-authors
- Peter Valent (15 shared papers)Michael Pfeilstöcker (11 shared papers)Reinhard Stauder (12 shared papers)Detlef Haase (6 shared papers)Christa Fonatsch (6 shared papers)Thomas Nösslinger (9 shared papers)Friedrich Wimazal (8 shared papers)Christian Steidl (4 shared papers)
- Journals
- Blood (9 papers)Annals of Hematology (3 papers)Leukemia Research (3 papers)Journal of Clinical Oncology (2 papers)British Journal of Haematology (2 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Otto Krieger
34 papers receiving 1.5k citations
Otto Krieger's Hit Papers
Peers
Comparison fields: 5 of 69
- Hematology 1.1k
- Genetics 432
- Emergency Medicine 131
- Pathology and Forensic Medicine 154
- Oncology 212
Countries citing papers authored by Otto Krieger
This map shows the geographic impact of Otto Krieger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Otto Krieger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Otto Krieger more than expected).
Fields of papers citing papers by Otto Krieger
This network shows the impact of papers produced by Otto Krieger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Otto Krieger. The network helps show where Otto Krieger may publish in the future.
Co-authors
The 25 scholars most cited alongside Otto Krieger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients Hit paper breakdown → | 2007 | 540 |
| 2 | 2007 | 357 | |
| 3 | 1999 | 128 | |
| 4 | 2011 | 89 | |
| 5 | 2016 | 58 | |
| 6 | 2002 | 50 | |
| 7 | 2009 | 48 | |
| 8 | 2002 | 34 | |
| 9 | 2010 | 33 | |
| 10 | 2008 | 27 | |
| 11 | 1993 | 23 | |
| 12 | 1989 | 18 | |
| 13 | 2014 | 17 | |
| 14 | 2007 | 13 | |
| 15 | 2013 | 12 | |
| 16 | 2011 | 9 | |
| 17 | 2000 | 9 | |
| 18 | 2008 | 8 | |
| 19 | 2006 | 7 | |
| 20 | 2005 | 6 |
About Otto Krieger
Otto Krieger is a scholar working on Hematology, Genetics, Molecular Biology, Public Health, Environmental and Occupational Health and Pathology and Forensic Medicine, having authored 37 papers that have together received 1.5k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (18 papers), Acute Lymphoblastic Leukemia research (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Lymphoma Diagnosis and Treatment (6 papers), Chronic Myeloid Leukemia Treatments (4 papers), Eosinophilic Disorders and Syndromes (4 papers), Retinoids in leukemia and cellular processes (3 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Hematology (1.1k citations), Genetics (432 citations), Emergency Medicine (131 citations), Pathology and Forensic Medicine (154 citations) and Oncology (212 citations). Otto Krieger has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Peter Valent, Michael Pfeilstöcker, Reinhard Stauder, Detlef Haase, Christa Fonatsch, Thomas Nösslinger, Friedrich Wimazal, Christian Steidl, Barbara Hildebrandt and Julie Schanz. Their work appears in journals such as Blood, Annals of Hematology, Leukemia Research, Journal of Clinical Oncology and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.